INBIOS INTERNATIONAL INC: federal contracts won
Federal contracts of $10,000 or more awarded to this company since October 2020 (FY2021), from USAspending.gov. UEI: CNJNQ1GMSN55
12contracts won
$127,208,173total obligated
$3,276,734median contract
Apr 20, 2026most recent start
Agencies it works for
| Agency | Contracts | Obligated |
|---|---|---|
| Department of Defense | 5 | $90,971,573 |
| Department of Health and Human Services | 7 | $36,236,601 |
Industries (NAICS)
| NAICS | Contracts | Obligated |
|---|---|---|
| 325413 In-Vitro Diagnostic Substance Manufacturing | 4 | $75,394,258 |
| 541711 Research and development in biotechnology | 4 | $37,032,173 |
| 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | 2 | $13,631,879 |
| 541714 Research and Development in Biotechnology (except Nanobiotechnology) | 2 | $1,149,864 |
Where it works
Recent contracts
| Contract | Winner | Agency | Obligated | Start |
|---|---|---|---|---|
| INBIOS REAGENTS KITS
75D30126P20991 · NAICS 325413 In-Vitro Diagnostic Substance Manufacturing · San Juan, PR |
— | Department of Health and Human Services Centers for Disease Control and Prevention |
$62,258 | Apr 20, 2026 Ends: Sep 19, 2026 |
| TOPIC 455: DEVELOPMENT OF A RAPID AT-HOME TEST TO DETECT PROSTATE-SPECIFIC ANTIGEN USING SELF-COLLECTED FINGER STICKBLOOD
75N91024C00078 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Seattle, WA |
— | Department of Health and Human Services National Institutes of Health |
$399,866 Potential value: $454,183 |
Sep 16, 2024 Ends: Sep 15, 2025 |
| OVER THE COUNTER (OTC) COVID-19 TESTS
75A50223C00041 · NAICS 325413 In-Vitro Diagnostic Substance Manufacturing · Seattle, WA |
— | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response |
$20,736,000 | Sep 20, 2023 Ends: Mar 19, 2025 |
| THE PURPOSE OF THIS CONTRACT IS TO PROCURE OVER THE COUNTER (OTC) COVID-19 TESTS.
75A50223C00003 · NAICS 325413 In-Vitro Diagnostic Substance Manufacturing · Seattle, WA |
— | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response |
$2,596,000 | Dec 07, 2022 Ends: Feb 15, 2023 |
| COVID-19 OTC TEST KIT
W58P0522C0014 · NAICS 325413 In-Vitro Diagnostic Substance Manufacturing · Seattle, WA |
— | Department of Defense Department of the Army |
$52,000,000 | Feb 17, 2022 Ends: Sep 09, 2022 |
| COVID-19 - DHHS/BARDA - INBIOS INTERNATIONAL, INC. PRODUCTION CAPACITY EXPANSION - ACTION AWARDED UNDER CSO FA7013-20-S-0002
FA865621C8877 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Seattle, WA |
— | Department of Defense Department of the Air Force |
$12,670,301 | Oct 30, 2020 Ends: Jun 30, 2021 |
| MEDICAL RESEARCH AND DEVELOPMENT CONTRACT ARMY SBIR SEQ PH PROPOSAL NO. A28137 TOPIC A14049 TITLE DIAGNOSTIC DEVICE FOR NOROVIRUS GASTROENT…
W81XWH20C0071 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Seattle, WA |
— | Department of Defense Department of the Army |
$961,577 | Sep 23, 2020 Ends: Jan 22, 2023 |
| COVID-19-FDA EUA ANTIGEN DETECTION- FDA FAST TRACK SEROLOGY ASSAY OPTIMIZATION
W81XWH20F0253 · NAICS 541711 Research and development in biotechnology · Seattle, WA |
— | Department of Defense Defense Health Agency |
$24,533,391 Potential value: $25,655,995 |
Jun 15, 2020 Ends: May 31, 2025 |
| COVID-19 -- INBIOS R&D OF AN ANTIBODY DIAGNOSTIC
75A50120C00090 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Seattle, WA |
— | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response |
$749,998 | Apr 24, 2020 Ends: Oct 01, 2021 |
| OTHER DIRECT COST
W81XWH19F0423 · NAICS 541711 Research and development in biotechnology · Seattle, WA |
— | Department of Defense Department of the Army |
$806,303 | Jul 22, 2019 Ends: Jun 21, 2021 |
| IGF::OT::IGF - BASE PERIOD AWARD TO INBIOS INTERNATIONAL, INC. FOR POINT-OF-CARE IMMUNOASSAY FOR DIAGNOSIS OF INHALATIONAL ANTHRAX
HHSO100201700029C · NAICS 541711 Research and development in biotechnology · Seattle, WA |
— | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response |
$3,957,468 Potential value: $12,051,614 |
Sep 26, 2017 Ends: Sep 30, 2027 |
| IGF::OT::IGF INBIOS - DEVELOPMENT OF POINT-OF-CARE ANDLABORATORY-BASED IMMUNOASSAYS FOR PRESUMPTIVE DIAGNOSIS OF ZIKA VIRUS INFECTION
HHSO100201600014C · NAICS 541711 Research and development in biotechnology · Seattle, WA |
— | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response |
$7,735,011 | Jul 27, 2016 Ends: Dec 31, 2023 |
Source: USAspending.gov (prime contract awards of $10,000 or more). Values are amounts obligated to date. Recent months can still change as agencies report late.